ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 121 filers reported holding ANAPTYSBIO INC in Q4 2018. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $7,223,000 | -22.3% | 128,006 | +0.6% | 0.02% | -19.2% |
Q1 2019 | $9,295,000 | +26.3% | 127,247 | +10.3% | 0.03% | +4.0% |
Q4 2018 | $7,361,000 | -35.4% | 115,400 | +1.0% | 0.02% | -21.9% |
Q3 2018 | $11,402,000 | +57.2% | 114,286 | +11.9% | 0.03% | +45.5% |
Q2 2018 | $7,253,000 | -30.7% | 102,114 | +1.5% | 0.02% | -35.3% |
Q1 2018 | $10,470,000 | +59.9% | 100,614 | +54.7% | 0.03% | +61.9% |
Q4 2017 | $6,549,000 | – | 65,030 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 3,688,448 | $371,500,000 | 60.25% |
Cormorant Asset Management, LP | 1,251,485 | $126,050,000 | 13.20% |
BVF INC/IL | 594,397 | $59,868,000 | 7.22% |
VHCP Management II, LLC | 282,550 | $28,458,000 | 6.82% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 812,484 | $81,833,000 | 3.22% |
Iguana Healthcare Management, LLC | 40,000 | $4,029,000 | 2.62% |
Perceptive Advisors | 756,387 | $76,183,000 | 2.52% |
Cormorant Asset Management, LP | 135,000 | $13,597,000 | 1.42% |
EAM Global Investors LLC | 21,734 | $2,189,000 | 1.12% |
PFM Health Sciences, LP | 425,896 | $42,896,000 | 1.02% |